StockData
Purple Biotech Ltd. logo

Purple Biotech Ltd. (PPBT) stock

PPBTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 19, 2026Score 1/30
$1.71+0.03 (+1.79%)

Close on Nov 17, 2026Market cap $1.59MP/E 0.0Yield –

Purple Biotech pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Purple Biotech's pe ratio was 0.0× on Nov 11, 2026, against 0.0× a year earlier. Over the last 5 years it ranged from 0.0× to 0.2×, with a median of 0.0×.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.0×+0.0
2025Dec 31, 20250.0×−0.0
2024Dec 31, 20240.0×−0.0
2023Dec 29, 20230.0×+0.0
2022Dec 30, 20220.0×−0.2
2021Dec 31, 20210.2×−1.1
2020Dec 31, 20201.3×−0.9
2019Dec 31, 20192.1×+1.6
2018Dec 31, 20180.5×−0.6
2017Dec 29, 20171.1×+0.4
2016Dec 30, 20160.7×–

More Purple Biotech figures

See a number that looks wrong?